Swiss National Bank’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Sell |
74,400
-900
| -1% | -$39.3K | ﹤0.01% | 1524 |
|
|
2025
Q1 | $2.06M | Sell |
75,300
-900
| -1% | -$24.6K | ﹤0.01% | 1745 |
|
|
2024
Q4 | $3.07M | Buy |
76,200
+10,300
| +16% | +$414K | ﹤0.01% | 1601 |
|
|
2024
Q3 | $3.12M | Sell |
65,900
-24,200
| -27% | -$1.15M | ﹤0.01% | 1602 |
|
|
2024
Q2 | $2.69M | Buy |
90,100
+10,400
| +13% | +$310K | ﹤0.01% | 1658 |
|
|
2024
Q1 | $3.2M | Buy |
79,700
+8,700
| +12% | +$350K | ﹤0.01% | 1578 |
|
|
2023
Q4 | $1.81M | Sell |
71,000
-8,100
| -10% | -$206K | ﹤0.01% | 1906 |
|
|
2023
Q3 | $1.1M | Buy |
79,100
+13,000
| +20% | +$181K | ﹤0.01% | 2194 |
|
|
2023
Q2 | $1.52M | Sell |
66,100
-10,900
| -14% | -$251K | ﹤0.01% | 2061 |
|
|
2023
Q1 | $2.28M | Sell |
77,000
-4,400
| -5% | -$130K | ﹤0.01% | 1763 |
|
|
2022
Q4 | $2.03M | Buy |
81,400
+1,700
| +2% | +$42.4K | ﹤0.01% | 1886 |
|
|
2022
Q3 | $1.74M | Buy |
79,700
+1,000
| +1% | +$21.8K | ﹤0.01% | 1967 |
|
|
2022
Q2 | $1.55M | Buy |
78,700
+11,800
| +18% | +$232K | ﹤0.01% | 2095 |
|
|
2022
Q1 | $2.83M | Buy |
66,900
+5,100
| +8% | +$216K | ﹤0.01% | 1828 |
|
|
2021
Q4 | $3.92M | Buy |
61,800
+1,300
| +2% | +$82.5K | ﹤0.01% | 1627 |
|
|
2021
Q3 | $3.55M | Buy |
60,500
+35,800
| +145% | +$2.1M | ﹤0.01% | 1689 |
|
|
2021
Q2 | $1.2M | Sell |
24,700
-500
| -2% | -$24.3K | ﹤0.01% | 2398 |
|
|
2021
Q1 | $979K | Hold |
25,200
| – | – | ﹤0.01% | 2350 |
|
|
2020
Q4 | $1.56M | Buy |
+25,200
| New | +$1.56M | ﹤0.01% | 2057 |
|